PER
Click for more information
0.00% 8.4¢ percheron therapeutics limited

Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial, page-31

  1. Quay Street
    455 Posts.
    lightbulb Created with Sketch. 58
    clock Created with Sketch.
    09/06/23
    15:10
    Post #: 68219707
    We dhould remember that DMD affects the skeleton of the brain resulting lower intellectual performance.
    ATL1102 has been used to treat MS so it does cross blood brain barrier.
    May it also improve CNS issues?
    ANP Price at posting: 7.4¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AL8 "What is the focus of AL8 and how is management going to attract shareholders to the registry?"
right-arrow Created with Sketch.
NEWS Dominos looks tasty and tempting, but could be too spicy and even dicey
right-arrow Created with Sketch.
NEWS From the Floor: Gold questions answered...
right-arrow Created with Sketch.
TLX Telix dips as pharma giant abandons US IPO for NASDAQ listing – despite record run
right-arrow Created with Sketch.
TSO Tesoro reports gold grading 173g/t in Chile, sending share price soaring
right-arrow Created with Sketch.
NEWS MiningNews Select Conference: Inflation and global shifts pose funding challenges for Aus miners
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $75.73M
Open High Low Value Volume
8.4¢ 8.5¢ 8.4¢ $31.98K 379.3K

Buyers (Bids)

No. Vol. Price($)
2 262571 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 119843 1
View Market Depth
Last trade - 14.51pm 19/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.